Background
There is a marked association between metabolic syndrome (MS) and increased cardiovascular risk. Moreover, nondipping (patients with <10% decline in the asleep relative to the awake blood pressure (BP) mean) has also been associated with increased cardiovascular morbidity and mortality.
methodS
We investigated the association between MS and impaired nocturnal BP decline in 1,770 nondiabetic, untreated hypertensive patients (824 men and 946 women), 48.7 ± 13.2 years of age. BP was measured by ambulatory monitoring for 48 h to increase reproducibility of the dipping pattern. Physical activity was simultaneously monitored every minute by wrist actigraphy.
reSultS MS was present in 42.4% of the patients. The prevalence of a nondipper BP profile was significantly higher in patients with MS (46.1% vs. 37.5% in patients without MS, P < 0.001). Patients with MS were characterized by significant elevations in uric acid (5.9 mg/dl vs. 5.2 mg/dl, P < 0.001), fibrinogen (314 mg/dl vs. 304 mg/dl, P = 0.021), and globular sedimentation rate (13.8 mm vs. 11.6 mm, P < 0.001). Nondipping was significantly associated to the presence of MS in a multiple logistic regression model adjusted by other significant confounding factors, including age, serum creatinine, and cigarette smoking. The single most relevant factor in the definition of MS associated to nondipping was elevated waist perimeter.
articles

Nondipping in Metabolic Syndrome
We have previously documented strong correlations between the sleep-time-relative BP decline (i.e., awake/asleep BP ratio) expressed as a continuous variable and some of the individual components of MS, mainly fasting glucose and abdominal obesity. 16 However, the association between MS and a nondipper BP pattern seems controversial. [17] [18] [19] [20] [21] [22] [23] This might be due, among other factors, to differences in studied populations (normotensive subjects, untreated hypertensives, treated hypertensives), relatively small samples, the differing effect of the individual components of MS on an altered BP pattern, and the frequent use of low-reproducible single-24-h ambulatory BP monitoring (ABPM). Accordingly, we have investigated the association between MS and impaired nocturnal BP decline in a large population of nondiabetic untreated patients with essential hypertension who were evaluated by 48-h ABPM in order to increase reproducibility of the dipping BP pattern. 24, 25 
methodS
Inclusion and exclusion criteria. Inclusion criteria were age ≥18 years and a diagnosis of previously untreated grade 1 or 2 uncomplicated essential hypertension according to the European Society of Hypertension-European Society of Cardiology guidelines, 26 as determined by repeated (within the 3 months previous to recruitment) conventional clinic BP measurements (systolic BP (SBP) 140-179 mm Hg and/or diastolic BP (DBP) 90-109 mm Hg), and corroborated by 48-h ABPM at the time of recruitment. The diagnosis of hypertension based on 48-h ABPM required at least one out of four mean values above the following thresholds: an awake BP mean of ≥135 and/or ≥85 mm Hg for SBP and DBP, respectively, or an asleep BP mean ≥120 and/or ≥70 mm Hg. 26 Thus, subjects with white-coat hypertension were not included in the study.
Pregnant women, shift workers, heavy drinkers (alcohol intake >80 g/day), heavy smokers (>20 cigarette/day), and heavy exercisers were excluded, as were individuals with either severe arterial hypertension (grade 3, clinic BP ≥180, and/ or ≥110 mm Hg for SBP and DBP, respectively), type 1 or 2 diabetes, or secondary arterial hypertension and cardiovascular disorders, including concomitant unstable angina pectoris, heart failure, stroke, life-threatening arrhythmia, nephropathy, retinopathy, or prior (within the last year) myocardial infarction or coronary revascularization.
Study design. This was a cross-sectional study conducted at the Hospital Clínico Universitario, Santiago de Compostela, Spain, between 2000 and 2007. With those inclusion/exclusion criteria we identified 1,770 nondiabetic untreated hypertensive patients (824 men and 946 women), 48.7 ± 13.2 years of age, who completed the study and provided all required information. The Ethics Committee of Clinical Research approved the study. All subjects gave written informed consent.
MS was defined according to the revised ATP-III criteria, 3 namely, presence of at least three of the five following factors: elevated waist circumference (≥102 cm in men, ≥88 cm in women), elevated triglycerides, (≥150 mg/dl or drug treatment for elevated triglycerides) reduced HDL-cholesterol (<40 mg/dl in men, <50 mg/dl in women or drug treatment for reduced HDL-cholesterol), elevated BP (≥130 mm Hg in SBP and/or ≥85 mm Hg in DBP), and elevated fasting glucose (≥100 mg/dl). The demographic and analytical characteristics of the participants divided according to presence or absence of MS are described in Table 1 .
Blood samples were obtained in the clinic from the antecubital vein between 8 and 9 AM after nocturnal fasting within the same week when 48-h ABPM was initiated. Blood was analyzed for the variables described in Table 1 using routine automatic techniques at the hospital laboratory. The same investigator measured waist and hip circumferences of all patients according to the methodology established by the ATP-III. 3 Diagnosis of obstructive sleep apnea (apnea/hypopnea indez ≥10) was corroborated by overnight polysomnography at the clinic in patients with suspicion of having the condition because of daytime sleepiness, loud snoring, nocturnal choking, and awakenings, cease-breathing events, or all four of these as reported by the patient or a bed mate. Just before starting ABPM, six clinic BP measurements were obtained after the patient had rested in a seated position for at least 10 min, using a validated automatic oscillometric device (HEM-705IT; Omron Health Care, Vernon Hills, IL).
ABPM assessment. The SBP, DBP, and heart rate of each participant were automatically measured every 20 min from 7 AM to 11 PM and every 30 min during the night for 48 consecutive hours with a properly calibrated SpaceLabs 90207 device (SpaceLabs, Issaquah, WA). Participants were instructed to go about their usual activities with minimal restrictions but to follow a similar schedule during the 2 days of ABPM and to avoid daytime napping.
BP series were not considered valid for analysis if >30% of the measurements were missing, if data were missing for an interval of >2 h, if data were obtained while patients had an irregular rest-activity schedule, or if the nighttime sleep period was <6 h or >12 h during ABPM. Protocol-correct data series were collected from 1,770 patients and, therefore, included in this study. Profiles of 29 additional subjects fulfilling the inclusion criteria were eliminated due to inadequate BP sampling.
Actigraphy. All participants wore an actigraph (MiniMotion-Logger; Ambulatory Monitoring, Ardsley, NY) on the dominant wrist to monitor physical activity every minute during both ABPM sessions. This compact (about half the size of a wristwatch) device functions as an accelerometer. We synchronized the internal clocks of the actigraph and the ABPM device through their respective interfaces using the same computer. The actigraphy data were used to corroborate absence of daytime napping, and to determine the beginning and the end of daytime activity and nocturnal sleep so that the awake and asleep BP means for each patient could be determined with accuracy.
Statistical methods.
To correct for measurement errors and outliers, BP and heart rate were edited according to conventional criteria. 27 Thus, readings of SBP >250 or <70 mm Hg, DBP >150 or <40 mm Hg, and pulse pressure (PP, difference between SBP and DBP) >150 or <20 mm Hg were automatically discarded. The awake/asleep BP ratio (an index of BP dipping), defined as the percent decrease in BP during the hours of nocturnal rest relative to the mean BP obtained during the hours of daytime activity, was calculated as: ((awake BP mean -sleep-time BP mean)/awake BP mean) × 100, using all data sampled by ABPM for 48 consecutive hours. For comparative purposes, patients were defined as dipper if the percent decline in SBP while asleep (awake/asleep SBP ratio) was ≥10%, and as nondipper otherwise.
The awake, asleep, and 24-h BP means as well as the awake/ asleep BP ratio as a continuous variable were compared by analysis of variance between groups of patients divided according to presence or absence of MS. The demographic and clinical characteristics in Table 1 were compared among these groups by analysis of variance (quantitative variables) or nonparametric χ 2 -test. We also compared between groups the proportion of patients with clinic PP ≥65 mm Hg, as well as the proportion of patients with 24-h PP mean >53 mm Hg, as these two threshold values are considered abnormal and have been shown to predict adverse prognosis. 28, 29 The potential contribution of influential factors on the dipping classification, as defined above, was established by logistic regression analysis, using potential correlates described in Table 1 . Because the dipping classification is arbitrary, we also evaluated the potential correlates with the awake/asleep SBP ratio as a continuous variable by multiple regression analysis.
reSultS demographic characteristics and analytical parameters
MS was present in 42.4% of the patients. Subjects with MS were characterized not only by the expected higher values of body mass index, waist and hip circumferences, glucose and triglycerides, and lower values of HDL-cholesterol implicit in the definition of the syndrome, but also by significant higher levels of total cholesterol, low-density lipoprotein-cholesterol, uric acid, and plasma fibrinogen ( Table 1) . Leukocyte count, hemoglobin, hematocrit and globular sedimentation rate were also significantly higher in patients with MS ( Table 1) . Clinic BP, including PP, was significantly higher among patients with MS as compared to those without MS ( Table 1) . The proportion of patients with clinic PP ≥65 mm Hg was almost 50% higher among patients with MS. Estimated glomerular filtration rate was slightly but not significantly lower in patients with MS.
aBPm characteristics
Patients with MS have a significant higher level of SBP and a significant lower level of DBP (mainly during daytime) than patients without MS ( Table 2 ). The largest differences in BP between groups of patients divided according to presence or absence of MS were obtained for the asleep SBP mean ( Table 2) . Differing trends for SBP and DBP between patients with and without MS lead to differences between groups in PP ( Table 2) , significantly higher for the entire 24 h among patients with MS. The proportion of patients with a 24 h-PP mean >53 mm Hg was significantly higher, from 21% to 35%, in patients with MS.
Results also document a statistically significant reduction in the awake/asleep ratio of both SBP and DBP in patients articles
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with MS (P < 0.001; Table 2 ). Thus, the prevalence of a nondipper BP profile was significantly higher in patients with MS (46.1% vs. 37.5% in patients without MS, P < 0.001; Table 2 ). Despite these results, the mean activity during sleep and the hours of duration of nocturnal sleep, as determined by wrist actigraphy, were comparable among groups ( Table 2) . Mean activity during daytime waking hours was lower among patients with MS. Comparison of results from Tables 1 and 2 also indicate a higher difference between clinic and awake BP mean) for both SBP and DBP among patients with MS.
modeling the awake/asleep BP ratio
We investigated the contributing influential factors on the dipping classification by stepwise logistic regression analysis. When we used for analysis all potentially influential variables listed in Table 1 (i.e., age, smoking, creatinine, gender, uric acid, globular sedimentation rate, and estimated glomerular filtration rate, all showing a significant correlation with nondipping) as well as MS (0 = no, 1 = yes), results from backward stepwise logistic regression indicated that nondipping (as a categorical variable) was simultaneously and significantly associated to the presence of MS, increased age, and increased serum creatinine (Table 3) , while cigarette smoking increased the awake/asleep BP ratio toward a more dipping pattern (due to the expected elevation of awake BP associated to the pressor effect of smoking). When we used for analysis the potentially influential variables listed above as well as the individual components in the definition of MS, results indicated that nondipping was significantly and simultaneously associated to increased age, female gender, increased serum creatinine, and increased waist circumference (model 2, Table 3 ). No other variable showed a significant relation with nondipping from multivariable logistic Odds ratio (95% confidence intervals) for the awake/asleep systolic blood pressure ratio as a discrete variable (0 = nondipper, 1 = dipper), calculated for each year increase in age, each mg/dl increase in serum creatinine, and each 1 cm increase in waist circumference; cigarette smoking defined as 0 = no, 1 = yes; MS defined as 0 = no, 1 = yes; gender defined as 1 = male, 2 = female. The variables used as potential influential factors were those from articles
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regression analysis and, therefore, they were omitted from the final models provided in Table 3 .
Because the dipping/nondipping classification is somehow arbitrary, we further analyzed the awake/asleep BP ratio as a continuous variable. Among the individual components of MS, the awake/asleep SBP ratio was significantly correlated with waist circumference (r = -0.12, P < 0.001) and fasting glucose (r = -0.08, P < 0.01). The awake/asleep SBP ratio, however, showed no significant correlations with either clinic BP, HDL-cholesterol, or triglycerides (P > 0.29). Stepwise multiple regression analysis (backward elimination) was performed using all individual components in the definition of MS as well as variables from Table 1 showing a significant linear correlation with the awake/asleep BP ratio (initial model in Table 4 ). Results reveal that higher waist circumference, higher age, and higher serum creatinine are significant joint predictors of a lower awake/asleep SBP ratio ( Table 4) . Stepwise forward selection provided to the same final model for the awake/ asleep SBP ratio.
diScuSSion
Results from this cross-sectional study on a large population of untreated patients with essential hypertension evaluated by 48-h ABPM document a significant increase of a blunted nocturnal BP decline BP in patients with MS ( Table 2) . This may be clinically relevant because, although the mechanism underlying the lack of nocturnal decline in BP is unclear, nondipping has been related to an increase in end-organ injury and cardiovascular events. [13] [14] [15] Overall, these studies indicate loss of the expected >10% sleep-time decline in BP constitutes a significant risk factor of cardiovascular mortality that is independent of the 24-h BP mean, that is, the presence or absence of an elevated BP above the threshold used to diagnose hypertension. Moreover, nighttime SBP seems to be a better predictor of cardiovascular mortality than the awake or 24-h BP means. 14, 30, 31 Patients with MS in the present study were characterized by a significant increase in asleep SBP ( Table 2) . The proportion of patients with obstructive sleep apnea was slightly, but not significantly higher, among patients with MS. This result must be taken with caution, as we did not performed polysomnography in all patients.
Several other studies investigating the potential relationship between MS and the circadian BP pattern not always found such relation, [17] [18] [19] 21, 22 leading to somehow contradictory results. For instance, Cuspidi et al. 18, 19 found no significant difference in nocturnal BP patterns, assessed by two consecutive 24-h ABPM sessions, in untreated essential hypertensive patients with MS compared to those without it. Similarly to the findings in our study, Tartan et al. 20 documented a significant elevation in nighttime SBP in hypertensive patients with a high MS score, based on numeric grading of the different factors included in the ATP-III definition for MS. This MS score was also an independent predictor of a nondipper pattern in BP. 20 Vyssoulis et al. 23 also documented an elevated prevalence of abnormal dipping pattern in a large group of untreated hypertensive patients with MS. The authors reported an increased prevalence of nondipping with elevated number of components in the definition of MS. However, the relative influence in the lack of proper nocturnal BP decline of each single component was not investigated. Despite similar conclusions, there are three additional major differences with our study: the threshold value of 110 mg/dl for fasting glucose (instead of the more recently proposed 100 mg/dl used here), the lack of actigraphy to properly identify activity and resting periods, and the use of low-reproducible ABPM for a unique 24-h span.
Results from logistic regression indicate that the presence of MS is a significant influential factor of nondipping, corrected by other significant covariates including age and progressive impaired renal function. Among the individual components included in the ATP-III definition of MS, the decrease in awake/ asleep BP ratio was only correlated with increased values of glucose and, to a larger extent, waist circumference. Corroborating previous findings on the impact of obesity on impaired circadian BP regulation, 32 abdominal obesity was the only significant influential factor on the awake/asleep SBP ratio (expressed as a continuous variable), corrected by age, gender, and serum Table 4) . Our results also corroborate previous findings on the increased white-coat effect in overweight and obesity, 32 more prevalent among patients with MS. Our study also demonstrates that presence of MS is characterized by a highly statistically significant elevation of clinic and ambulatory PP. These results are consistent with those from a recent cross-sectional study on a smaller population of hypertensive patients. 33 Mulè et al. 33 found a significant increase in the 24-h PP mean among patients with MS (51 mm Hg vs. 48 mm Hg for patients without MS). These values are very similar to those provided in Table 2 for the present study. These results seem relevant, as increased PP is an independent marker of cardiovascular risk, mainly for myocardial infarction, congestive heart failure, and cardiovascular deaths. 34, 35 The elevated levels of PP in patients with MS may thus contribute to explain the enhanced cardiovascular risk associated with MS.
The definition of nocturnal hypertension on the basis of the dipper concept has been frequently criticized due to the inability to reproduce over time the classification of patients into dippers and nondippers. 36 This may partly be due to the fact that most studies, including those failing to show a relation between nondipping and MS, [17] [18] [19] 21, 22 relied on 24-h ABPM. The advantages of 48 h sampling over the most common 24-h ABPM, and in terms of reproducibility of results and dipping classification of patient, have been documented previously. 24, 25, 36 Uncertainly in the classification of a patient as dipper may be reduced from 42% to just 6% by expanding monitoring from 24 to 48 h, 24 as the proper estimation of mean BP values has been demonstrated to be more dependent on duration of monitoring than on sampling rate. 25 Results from this study further indicate that about 21% of the patients changed their dipping classification from one day to the next when relying on 24-h sampling, thus limiting the short-term reproducibility of the awake/asleep BP ratio calculated on the basis on a unique 24-h BP profile. 25 In conclusion, this large cross-sectional study on patients with untreated essential hypertension evaluated by 48-h ABPM demonstrates a significant increase of a blunted nocturnal BP decline in patients with MS. This finding indicates that MS should be included among the clinical situations in which ABPM is recommended.
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